191 related articles for article (PubMed ID: 28912174)
1. Senescence is a Spi1-induced anti-proliferative mechanism in primary hematopoietic cells.
Delestré L; Cui H; Esposito M; Quiveron C; Mylonas E; Penard-Lacronique V; Bischof O; Guillouf C
Haematologica; 2017 Nov; 102(11):1850-1860. PubMed ID: 28912174
[TBL] [Abstract][Full Text] [Related]
2. The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia.
Rimmelé P; Esposito M; Delestré L; Guervilly JH; Ridinger-Saison M; Despras E; Moreau-Gachelin F; Rosselli F; Guillouf C
Oncotarget; 2017 Jun; 8(23):37104-37114. PubMed ID: 28415748
[TBL] [Abstract][Full Text] [Related]
3. A somatic mutation of GFI1B identified in leukemia alters cell fate via a SPI1 (PU.1) centered genetic regulatory network.
Anguita E; Gupta R; Olariu V; Valk PJ; Peterson C; Delwel R; Enver T
Dev Biol; 2016 Mar; 411(2):277-286. PubMed ID: 26851695
[TBL] [Abstract][Full Text] [Related]
4. Self-renewal of leukemia stem cells in Friend virus-induced erythroleukemia requires proviral insertional activation of Spi1 and hedgehog signaling but not mutation of p53.
Hegde S; Hankey P; Paulson RF
Stem Cells; 2012 Feb; 30(2):121-30. PubMed ID: 22083997
[TBL] [Abstract][Full Text] [Related]
5. EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription.
Ayoub E; Wilson MP; McGrath KE; Li AJ; Frisch BJ; Palis J; Calvi LM; Zhang Y; Perkins AS
Nat Commun; 2018 Oct; 9(1):4239. PubMed ID: 30315161
[TBL] [Abstract][Full Text] [Related]
6. Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells.
Shimabe M; Goyama S; Watanabe-Okochi N; Yoshimi A; Ichikawa M; Imai Y; Kurokawa M
Oncogene; 2009 Dec; 28(49):4364-74. PubMed ID: 19767769
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia.
Van Thillo Q; De Bie J; Seneviratne JA; Demeyer S; Omari S; Balachandran A; Zhai V; Tam WL; Sweron B; Geerdens E; Gielen O; Provost S; Segers H; Boeckx N; Marshall GM; Cheung BB; Isobe K; Kato I; Takita J; Amos TG; Deveson IW; McCalmont H; Lock RB; Oxley EP; Garwood MM; Dickins RA; Uyttebroeck A; Carter DR; Cools J; de Bock CE
Nat Commun; 2021 Jul; 12(1):4164. PubMed ID: 34230493
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the proto-oncogene Zfp521 by SPI1 (PU.1) and HOXC13.
Yu M; Al-Dallal S; Al-Haj L; Panjwani S; McCartney AS; Edwards SM; Manjunath P; Walker C; Awgulewitsch A; Hentges KE
Genesis; 2016 Oct; 54(10):519-533. PubMed ID: 27506447
[TBL] [Abstract][Full Text] [Related]
9. Fli-1 overexpression in erythroleukemic cells promotes erythroid de-differentiation while Spi-1/PU.1 exerts the opposite effect.
Vecchiarelli-Federico LM; Liu T; Yao Y; Gao Y; Li Y; Li YJ; Ben-David Y
Int J Oncol; 2017 Aug; 51(2):456-466. PubMed ID: 28586009
[TBL] [Abstract][Full Text] [Related]
10. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis.
Yang L; Liu L; Gao H; Pinnamaneni JP; Sanagasetti D; Singh VP; Wang K; Mathison M; Zhang Q; Chen F; Mo Q; Rosengart T; Yang J
J Hematol Oncol; 2017 Oct; 10(1):159. PubMed ID: 28974232
[TBL] [Abstract][Full Text] [Related]
11. T-ALL leukemia stem cell 'stemness' is epigenetically controlled by the master regulator SPI1.
Zhu H; Zhang L; Wu Y; Dong B; Guo W; Wang M; Yang L; Fan X; Tang Y; Liu N; Lei X; Wu H
Elife; 2018 Nov; 7():. PubMed ID: 30412053
[TBL] [Abstract][Full Text] [Related]
12. Zebrafish SPI-1 (PU.1) marks a site of myeloid development independent of primitive erythropoiesis: implications for axial patterning.
Lieschke GJ; Oates AC; Paw BH; Thompson MA; Hall NE; Ward AC; Ho RK; Zon LI; Layton JE
Dev Biol; 2002 Jun; 246(2):274-95. PubMed ID: 12051816
[TBL] [Abstract][Full Text] [Related]
13. BAF180 regulates cellular senescence and hematopoietic stem cell homeostasis through p21.
Lee H; Dai F; Zhuang L; Xiao ZD; Kim J; Zhang Y; Ma L; You MJ; Wang Z; Gan B
Oncotarget; 2016 Apr; 7(15):19134-46. PubMed ID: 26992241
[TBL] [Abstract][Full Text] [Related]
14. The proto-oncogene ERG in megakaryoblastic leukemias.
Rainis L; Toki T; Pimanda JE; Rosenthal E; Machol K; Strehl S; Göttgens B; Ito E; Izraeli S
Cancer Res; 2005 Sep; 65(17):7596-602. PubMed ID: 16140924
[TBL] [Abstract][Full Text] [Related]
15. RUNX1 induces DNA replication independent active DNA demethylation at SPI1 regulatory regions.
Goyal S; Suzuki T; Li JR; Maeda S; Kishima M; Nishimura H; Shimizu Y; Suzuki H
BMC Mol Biol; 2017 Apr; 18(1):9. PubMed ID: 28376714
[TBL] [Abstract][Full Text] [Related]
16. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.
Oikawa T; Yamada T; Kihara-Negishi F; Yamamoto H; Kondoh N; Hitomi Y; Hashimoto Y
Cell Death Differ; 1999 Jul; 6(7):599-608. PubMed ID: 10453070
[TBL] [Abstract][Full Text] [Related]
17. Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis.
Biavasco R; Lettera E; Giannetti K; Gilioli D; Beretta S; Conti A; Scala S; Cesana D; Gallina P; Norelli M; Basso-Ricci L; Bondanza A; Cavalli G; Ponzoni M; Dagna L; Doglioni C; Aiuti A; Merelli I; Di Micco R; Montini E
Nat Commun; 2021 Jul; 12(1):4559. PubMed ID: 34315896
[TBL] [Abstract][Full Text] [Related]
18. PU.1, a shared transcriptional regulator of lymphoid and myeloid cell fates.
Singh H; DeKoter RP; Walsh JC
Cold Spring Harb Symp Quant Biol; 1999; 64():13-20. PubMed ID: 11232277
[No Abstract] [Full Text] [Related]
19. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
Kastner P; Chan S
Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of erythropoiesis. Fine tuning of combinatorial multi-domain elements.
Perry C; Soreq H
Eur J Biochem; 2002 Aug; 269(15):3607-18. PubMed ID: 12153557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
